Metasurfaces are two-dimensional (2D), nanoengineered surfaces that interact strongly with electromagnetic waves and can ...

A team from the Faculty of Physics and the Center for Quantum Optical Technologies at the University of Warsaw has developed ...

The SHARON trial is ongoing and will be expanding to include patients without a BRCA or PALB2 mutation, and General Oncology plans to continue evaluating outcomes and long-term follow-up in this ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

NMIMS to roll out AI-led interviews with sentiment tracking, measuring facial expressions, tone, and confidence of MBA ...

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopeniaRecommendation based on LUNA 3 phase 3 study ...

Most recurrent ovarian cancer cases arise in patients previously treated with PARP inhibitors making these results noteworthy ...

OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...

The EMA has recommended a first-in-class Bruton’s tyrosine kinase inhibitor to treat immune thrombocytopenia in adults who are refractory to other treatments.

Detailed price information for Corcept Therapeutics (CORT-Q) from The Globe and Mail including charting and trades.

A team from the Faculty of Physics and the Centre for Quantum Optical Technologies at the University of Warsaw has developed a new type of all-optical ...

STOCKHOLM, SE / ACCESS Newswire / October 14, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the ...